市场调查报告书
商品编码
1463605
到 2030 年北美儿科骨科植入物市场预测 - 区域分析 - 按类型、应用和最终用户North America Pediatric Orthopedic Implants Market Forecast to 2030 - Regional Analysis - by Type, Application, and End User |
2022年北美儿童骨科植入物市值为15.6651亿美元,预计2030年将达到35.5634亿美元;预计2022年至2030年CAGR为10.8%。
治疗骨科出生缺陷的儿科手术数量不断增加,推动了北美小儿骨科植入物市场的发展
骨科缺陷是影响肌肉、骨骼和相关组织的后天或先天性异常。这些异常主要导致下肢肌肉失衡、瘫痪和感觉下降。先天性骨科残疾包括马蹄足、脊椎畸形、成骨不全、肌肉营养不良、肢体缺陷和骨感染。导致髋关节脱位的发育不良和导致足部弯曲或内八字的跖骨加合物也被归类为先天性骨科残疾。
骨科出生缺陷盛行率的增加推动了北美儿科骨科植入物市场的成长。根据美国疾病管制与盛行率中心(CDC) 的数据,马蹄内翻足是美国最常见的出生缺陷之一,到2022 年,该国约6,643 名婴儿受到影响。疾病会导致马蹄内翻足。此外,支持这些疾病的早期诊断和治疗的工具和技术的可用性有助于改善患者的治疗效果,进而促进儿科骨科植入物的采用。此外,过去十年中,儿科创伤病例有所增加。根据《Cureus》发表的一篇文章,儿童户外活动激增和意外伤害数量不断增加等因素继续推高儿科创伤的盛行率,这将在未来几年继续有利于北美儿科骨科植入物市场。
北美小儿骨科植入物市场概况
北美儿科骨科植入物市场分为美国、加拿大和墨西哥;美国在该地区占有最大的市场份额。北美市场的成长归因于出生畸形病例的增加以及该地区主要市场参与者不断实施成长策略。此外,主要国家不断增长的医疗支出将在预测期内推动该地区的市场成长。
北美小儿骨科植入物市场收入和 2030 年预测(百万美元)
北美小儿骨科植入物市场区隔
北美儿科骨科植入物市场按类型、应用、最终用户和国家进行细分。
根据类型,北美儿科骨科植入物市场分为髋关节植入物、脊椎植入物、膝关节植入物、牙科植入物、颅颜面植入物等。 2022 年,髋关节植入物领域占据最大的市场份额。
根据应用,北美儿科骨科植入物市场分为创伤和畸形、骨折、骨骼和关节感染、脊椎畸形等。 2022 年,创伤和畸形细分市场占据最大的市场份额。
根据最终用户,北美儿科骨科植入物市场分为医院、儿科诊所等。 2022 年,医院细分市场占据最大的市场。
按国家/地区划分,北美儿科骨科植入物市场分为美国、加拿大和墨西哥。 2022年,美国在北美儿童骨科植入物市场份额中占据主导地位。
Arthrex Inc、Johnson & Johnson、OrthoPediatrics Corp、Stryker Corp 和 WishBone Medical Inc 是北美儿科骨科植入物市场的一些领先公司。
The North America pediatric orthopedic implants market was valued at US$ 1,566.51 million in 2022 and is expected to reach US$ 3,556.34 million by 2030; it is estimated to grow at a CAGR of 10.8% from 2022 to 2030.
Rising Number of Pediatric Surgeries to Treat Orthopedic Birth Defects Fuels the North America Pediatric Orthopedic Implants Market
Orthopedic defects are acquired or congenital abnormalities that affect the muscles, skeleton, and related tissues. These abnormalities predominantly result in muscle imbalance, paralysis, and decreased sensation in the lower extremity. The congenital orthopedic disabilities include clubfoot, spine deformities, osteogenesis imperfecta, muscular dystrophy, limb defects, and bone infections. Developmental dysplasia causing hip dislocation and metatarsus adducts causing curved foot or in-toeing are also categorized as congenital orthopedic disabilities.
An increase in the prevalence of orthopedic birth defects drives the growth of the North America pediatric orthopedic implants market. According to the Centers for Disease Control and Prevalence (CDC), clubfoot is one of the most common birth defects in the US, and it affected ~6,643 babies in the country in 2022. Abnormal genes inherited from a parent and chromosomal disorders leading to a missing or abnormal gene in offspring are among the notable causes of orthopedic birth defects. Moreover, the availability of tools and technologies that support the early diagnosis and treatment of these disorders contribute to better patient outcomes, in turn, bolstering the adoption of pediatric orthopedic implants. Additionally, pediatric trauma cases have increased over the past decade. According to an article published in Cureus, factors such as a surge in outdoor activities among children and the growing number of accidental injuries continue to boost the prevalence of pediatric trauma, which would continue to benefit the North America pediatric orthopedic implants market in the coming years.
North America Pediatric Orthopedic Implants Market Overview
The North America pediatric orthopedic implants market is segmented into the US, Canada, and Mexico; the US held the largest share of the market in this region. The market growth in North America is attributed to the increasing cases of birth deformities and the rising implementation of growth strategies by key market players operating in this region. In addition, the growing health expenditures in major countries would drive market growth in the region during the forecast period.
North America Pediatric Orthopedic Implants Market Revenue and Forecast to 2030 (US$ Mn)
North America Pediatric Orthopedic Implants Market Segmentation
The North America pediatric orthopedic implants market is segmented type, application, end user, and country.
Based on type, the North America pediatric orthopedic implants market is segmented into hip implants, spine implants, knee implants, dental implants, craniomaxillofacial implants, and others. The hip implants segment held the largest market share in 2022.
Based on application, the North America pediatric orthopedic implants market is segmented into trauma and deformities, broken bones, bone and joint infections, spinal deformities, and others. The trauma and deformities segment held the largest market share in 2022.
Based on end user, the North America pediatric orthopedic implants market is segmented into hospitals, pediatric clinics, and others. The hospitals segment held the largest market share in 2022.
Based on country, the North America pediatric orthopedic implants market is segmented into the US, Canada, and Mexico. The US dominated the North America pediatric orthopedic implants market share in 2022.
Arthrex Inc, Johnson & Johnson, OrthoPediatrics Corp, Stryker Corp, and WishBone Medical Inc are some of the leading companies operating in the North America pediatric orthopedic implants market.